PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer

<p dir="ltr">Protein Kinase D1 (PKD1) is a serine/threonine kinase encoded by the <i>PRKD1</i> gene. PKD1 has been previously shown to be a prognostic factor in ERα+ tamoxifen-resistant breast tumors and PKD1 overexpression confers estrogen independence to ERα+ MCF7 cells...

Full description

Saved in:
Bibliographic Details
Main Author: Caroline Spasojevic (3619418) (author)
Other Authors: Elisabetta Marangoni (655592) (author), Sophie Vacher (233965) (author), Franck Assayag (3157383) (author), Didier Meseure (666209) (author), Sophie Château-Joubert (11410163) (author), Martine Humbert (252271) (author), Manale Karam (3619412) (author), Jean Marc Ricort (18696934) (author), Christian Auclair (140039) (author), Marie Regairaz (1465762) (author), Ivan Bièche (3492) (author)
Published: 2018
Subjects:
Biomedical and clinical sciences
Oncology and carcinogenesis
PKC
PKD
protein kinase D1
triple-negative breast cancer
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items